
|Articles|November 17, 2021
Daily OTC Pearl: Aspercreme 10%
Author(s)Saro Arakelians, PharmD
Trolamine salicylate is a pain-relieving compound closely related to aspirin, a nonsteroidal anti-inflammatory drug.
Advertisement
OTC/Lifestyle Pearl of the Day: Aspercreme 10%
Indication: Trolamine 
Insight:
- Aspercreme belongs to a class of drugs known as 
salicylates . - Trolamine salicylate is a pain-relieving compound closely related to aspirin, a nonsteroidal anti-inflammatory drug.
 - Aspercreme is for use on the 
skin only. Patients should know to not get this medication in theireyes , inside the nose ormouth , or inside thevagina . - Apply the medication to the affected area no more than 3 to 4 times a day. Rub in gently and thoroughly. After applying the medication, 
wash hands . - Do not apply this medication on broken or irritated 
skin . Do not bandage or tightly wrap the affected area or apply heat to the area. - Adverse effects may include blistering/peeling/redness/irritation at the application site, 
nausea /vomiting , andringing in the ears . - Aspercreme products contain the maximum percentage of lidocaine currently approved for OTC use.Versions containing lidocaine include Lidocaine cream, Lidocaine patch, Lidocaine spray, and Lidocaine liquid roll-on.
 
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
4
RSV May Complicate Multiple Myeloma Care Through Therapy Delays, Not Mortality Risk
5














































































































































































































